The psychedelic space was dealt a huge blow when the FDA decided not to approve MDMA-assisted therapy for PTSD under Lykos’ proposal. Was the FDA fair to Lykos? And what are the next steps for Lykos and MAPS? In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic […]
The post The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos? appeared first on Psychedelics Today.
